unknown
Stage
1
Investors
About
Vor Bio develops next-generation engineered cell therapies targeting diseases through novel immune cell programming technologies.
Explore Vor Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.